These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31936622)

  • 1. Exploring the Multi-Target Performance of Mitochondriotropic Antioxidants against the Pivotal Alzheimer's Disease Pathophysiological Hallmarks.
    Benfeito S; Fernandes C; Vilar S; Remião F; Uriarte E; Borges F
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31936622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Insight into the Design of Chemical Tools to Control Multiple Pathogenic Features in Alzheimer's Disease.
    Han J; Du Z; Lim MH
    Acc Chem Res; 2021 Oct; 54(20):3930-3940. PubMed ID: 34606227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel tacrine-grafted Ugi adducts as multipotent anti-Alzheimer drugs: a synthetic renewal in tacrine-ferulic acid hybrids.
    Benchekroun M; Bartolini M; Egea J; Romero A; Soriano E; Pudlo M; Luzet V; Andrisano V; Jimeno ML; López MG; Wehle S; Gharbi T; Refouvelet B; de Andrés L; Herrera-Arozamena C; Monti B; Bolognesi ML; Rodríguez-Franco MI; Decker M; Marco-Contelles J; Ismaili L
    ChemMedChem; 2015 Mar; 10(3):523-39. PubMed ID: 25537267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (-)-Meptazinol-melatonin hybrids as novel dual inhibitors of cholinesterases and amyloid-β aggregation with high antioxidant potency for Alzheimer's therapy.
    Cheng S; Zheng W; Gong P; Zhou Q; Xie Q; Yu L; Zhang P; Chen L; Li J; Chen J; Chen H; Chen H
    Bioorg Med Chem; 2015 Jul; 23(13):3110-8. PubMed ID: 26025073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer's Disease.
    Rampa A; Bartolini M; Pruccoli L; Naldi M; Iriepa I; Moraleda I; Belluti F; Gobbi S; Tarozzi A; Bisi A
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30061534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease.
    Chen Z; Digiacomo M; Tu Y; Gu Q; Wang S; Yang X; Chu J; Chen Q; Han Y; Chen J; Nesi G; Sestito S; Macchia M; Rapposelli S; Pi R
    Eur J Med Chem; 2017 Jan; 125():784-792. PubMed ID: 27736684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic β-hydroxy ketone derivative inhibits cholinesterases, rescues oxidative stress and ameliorates cognitive deficits in 5XFAD mice model of AD.
    Ahmad SI; Ali G; Muhammad T; Ullah R; Umar MN; Hashmi AN
    Mol Biol Rep; 2020 Dec; 47(12):9553-9566. PubMed ID: 33211296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer's disease.
    Singh YP; Tej GNVC; Pandey A; Priya K; Pandey P; Shankar G; Nayak PK; Rai G; Chittiboyina AG; Doerksen RJ; Vishwakarma S; Modi G
    Eur J Med Chem; 2020 Jul; 198():112257. PubMed ID: 32375073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donepezil-butylated hydroxytoluene (BHT) hybrids as Anti-Alzheimer's disease agents with cholinergic, antioxidant, and neuroprotective properties.
    Cai P; Fang SQ; Yang HL; Yang XL; Liu QH; Kong LY; Wang XB
    Eur J Med Chem; 2018 Sep; 157():161-176. PubMed ID: 30096650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-tuning the neuroprotective and blood-brain barrier permeability profile of multi-target agents designed to prevent progressive mitochondrial dysfunction.
    Benfeito S; Oliveira C; Fernandes C; Cagide F; Teixeira J; Amorim R; Garrido J; Martins C; Sarmento B; Silva R; Remião F; Uriarte E; Oliveira PJ; Borges F
    Eur J Med Chem; 2019 Apr; 167():525-545. PubMed ID: 30784884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
    Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
    Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cinnamamide-dibenzylamine hybrids: Potent neurogenic agents with antioxidant, cholinergic, and neuroprotective properties as innovative drugs for Alzheimer's disease.
    Wang J; Cai P; Yang XL; Li F; Wu JJ; Kong LY; Wang XB
    Eur J Med Chem; 2017 Oct; 139():68-83. PubMed ID: 28800459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pterostilbene-O-acetamidoalkylbenzylamines derivatives as novel dual inhibitors of cholinesterase with anti-β-amyloid aggregation and antioxidant properties for the treatment of Alzheimer's disease.
    Li Y; Qiang X; Li Y; Yang X; Luo L; Xiao G; Cao Z; Tan Z; Deng Y
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2035-9. PubMed ID: 26947607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New classes of carbazoles as potential multi-functional anti-Alzheimer's agents.
    Choubdar N; Golshani M; Jalili-Baleh L; Nadri H; Küçükkilinç TT; Ayazgök B; Moradi A; Moghadam FH; Abdolahi Z; Ameri A; Salehian F; Foroumadi A; Khoobi M
    Bioorg Chem; 2019 Oct; 91():103164. PubMed ID: 31398601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological Evaluation of 8-Hydroxyquinolines as Multi-Target Directed Ligands for Treating Alzheimer's Disease.
    Knez D; Sosič I; Pišlar A; Mitrović A; Jukič M; Kos J; Gobec S
    Curr Alzheimer Res; 2019; 16(9):801-814. PubMed ID: 31660830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of novel ferulic acid-memoquin hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
    Pan W; Hu K; Bai P; Yu L; Ma Q; Li T; Zhang X; Chen C; Peng K; Liu W; Sang Z
    Bioorg Med Chem Lett; 2016 May; 26(10):2539-2543. PubMed ID: 27072909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents.
    Mahdavi M; Hariri R; Mirfazli SS; Lotfian H; Rastergari A; Firuzi O; Edraki N; Larijani B; Akbarzadeh T; Saeedi M
    Chem Biodivers; 2019 Apr; 16(4):e1800488. PubMed ID: 30720917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of novel azaanthraquinone derivatives as potent multi-target inhibitors of inflammation and amyloid-β aggregation in Alzheimer's disease.
    Wang J; Li W; Qin J; Wang L; Wei S; Tang H
    Bioorg Chem; 2019 Mar; 83():477-486. PubMed ID: 30448726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective Effects of Quercetin in Alzheimer's Disease.
    Khan H; Ullah H; Aschner M; Cheang WS; Akkol EK
    Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31905923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.